KOGENATE

This brand name is authorized in Austria, Cyprus, Estonia, Ireland, Lithuania, Netherlands, New Zealand, Poland, Singapore, Tunisia, South Africa

Active ingredients

The drug KOGENATE contains one active pharmaceutical ingredient (API):

1 Factor VIII Octocog alfa UNII P89DR4NY54 - ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT

Octocog alfa (Full length recombinant human coagulation factor VIII (rDNA)) is a purified protein that has 2,332 amino acids. It is produced by recombinant DNA technology in baby hamster kidney cells (BHK) into which the human factor VIII gene has been introduced. Read about Octocog alfa

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B02BD02	Coagulation factor VIII	B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1202634, 1202656, 1202678, 1367366, 1489125
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1004818, 1004819, 1004820, 1005121, 1029335, 1029340, 1029342, 1031803, 1056129, 1056130
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 57673, 57681, 57703, 85731
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 13345, 14580, 8511, 8512, 8513
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100127170, 100127186, 100127192, 100188992, 100235384
Country: SG	Health Sciences Authority	Identifier(s): 13385P, 13386P, 13387P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 12693011H, 12693012H, 12693013H
Country: ZA	Health Products Regulatory Authority	Identifier(s): 29/8.1/0009, 29/8.1/0010, 29/8.1/0011, 41/8.1/1086, 41/8.1/1087, 41/8.1/1088